Jun 6th 2018

Alzheimer’s disease: why insulin is a new suspect

 

Johnson and Johnson recently announced that it was halting a clinical trial for a new Alzheimer’s drug after safety issues emerged. This latest failure adds to the dozens of large, costly clinical trials that have shown no effect in treating this devastating disease.

The growing list of failures should give us pause for thought – have we got the causes of Alzheimer’s all wrong?

In the first analysis of the disease, the German physician, Alois Alzheimer, noted odd changes in the brain of a patient who died of the condition. Alzheimer identified two kinds of protein aggregates that are not found in younger brains: plaques that are found between brain cells and tangles that are found inside brain cells.

Later research identified the proteins that made up the plaques as amyloid and those that form the tangles as tau. What these structures actually do is still under debate.

Unheeded warning

Alzheimer advised scientists not to jump to the conclusion that these proteins caused the disease. Unfortunately, his caution was ignored, and over the years it has become gospel that the build up of these proteins causes Alzheimer’s disease.

One problem is that it’s not possible to test, in a scientific experiment, if this theory is correct. Only in recent years has technology been developed that can test what these proteins do, and it is clearly not what scientists previously assumed. For example, genetically engineered mice that accumulate human amyloid in their brains show only mild impairment. But the pharmaceutical industry made up its mind a long time ago that amyloid is the culprit, and this has been the target for Alzheimer’s drugs ever since.

Alois Alzheimer’s warning was ignored. Wikimedia Commons

The aim of these drugs is to reduce the levels of amyloid in the brain, either by slowing down the formation of amyloid or by removing it from the brain. Both approaches have been tested many times now using different techniques and drug types. None of these trials have shown any effects, and some large drug companies, including Pfizer, have abandoned this area of research altogether.

The continued failure of new drugs to make a difference has to be interpreted as evidence that the amyloid protein is not the cause of Alzheimer’s disease. Some companies have changed their target to the tau protein. But again, drugs companies are assuming that a single protein is the cause of the disease.

Promising new avenues

Perhaps it is time to rethink the disease altogether. One approach is to look for genes that increase the risk of developing the disease. The problem with this approach is that there are surprisingly few of these genes, and they are rare. Alzheimer’s does not appear to be driven by gene mutations, so this approach does not shed new light on the underlying processes.

Another option is to look at the risk factors for developing Alzheimer’s. One of these is type 2 diabetes. Clearly, diabetes is very different from Alzheimer’s disease, so what’s the connection?

In diabetes, insulin becomes less effective at controlling blood sugar levels. But insulin does a lot more than just control blood sugar; it is a “growth factor”. Neurons (brain cells) are very dependent on growth factors, and if they don’t get enough, they die.

The loss of insulin’s growth factor effects in the brain appear to make neurons vulnerable to stress and reduce the brain’s ability to repair damage that accumulates over time. (Neurons live as long as we do, so there is a lot of time for damage to accrue.)

When looking at brain tissue taken from deceased Alzheimer’s patients, researchers found that insulin lost its effectiveness as a growth factor, even in people who were not diabetic. This observation suggests that diabetes drugs might be an effective treatment for people with Alzheimer’s. Some experiments showed impressive results in animal studies, and several clinical trials have started.

Testing these drugs in animal models of another neurodegenerative disorder, Parkinson’s disease, also showed impressive effects, and two clinical trials in Parkinson’s patients showed good protective effects. In one of the trials – a pilot study – the patients who received the diabetes drug did not get any worse for two years while the control group, who received a standard treatment for Parkinson’s, deteriorated significantly. The other trial, a larger trial with a placebo control, confirmed this result and showed no deterioration in the drug group during the 12 months of study.

To see any protective effect in the brain in a clinical trial is completely new, and it supports the new theory that Alzheimer’s and Parkinson’s disease are caused, at least in part, by a lack of growth factor activity in the brain. These new theories bring a fresh view on how these diseases develop and increase the likelihood of developing a drug treatment that makes a difference.

 

Christian Holscher, Professor of Neuroscience, Lancaster University

This article was originally published on The Conversation. Read the original article.

Browse articles by author

More Essays

Dec 10th 2018
The current exhibition of Eugène Delacroix (1798-1863) at New York’s Metropolitan Museum of Art – the first of its kind to be mounted in North America – is indeed an extraordinary revelation. Delacroix was one of the great creative minds of the nineteenth century: an artist who embodied the spirit of Romanticism, a dramatist and virtuoso of coloration who never ceased to experiment, to take inspiration from the old masters – from Veronese and Rubens, Rembrandt and Caravaggio – whose works he would often copy at the Louvre, “that book from which we learn to read,” as Cézanne put it.
Dec 6th 2018
Your body has two metabolically different states: fasted (without food) and post-fed. The absorptive post-fed state is a metabolically active time for your body. But is also a time of immune system activity. When we eat, we do not just take in nutrients – we also trigger our immune system to produce a transient inflammatory response. Inflammation is a normal response of the body to infection and injury, which provides protection against stressors. This means that just the act of eating each meal imparts a degree of physiological stress on the immune system. And so for people snacking around the clock, their bodies can often end up in a near constant inflammatory state.
Dec 5th 2018
Researchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA signature that appears to be common across cancer types. The test has yet to be conducted on humans, and clinical trials are needed before we know for sure if it can be used in the clinic.
Dec 4th 2018
The late great Russian-born novelist Vladimir Nabokov (pictured below by Michael Johnson) amassed a range of critical comments during his 78 years, more than enough to qualify him as a literary giant and keep his books in print. But most of the assessments have an edge – he was irascible, independent-minded, contradictory, arbitrary, arrogant, tongue-tied, obscene. For such a tumultuous life, he died in opposite conditions: quietly in Montreux, Switzerland, having spent his last 16 years with few friends and almost no family around him. Making sense of this unique talent has been a hobby of mine since the 1960s, enjoying his quirky prose style, his trilingual puns and his forays into forbidden territory, particularly with Bend Sinister, Lolita, Pnin, Pale Fire and Ada. Have I ever made sense of him?
Nov 26th 2018
There is now good evidence that the risks versus benefits of alcohol are strongly influenced by the type of alcohol and the way it is drunk.
Nov 14th 2018
Jean Gabin - pictured below by the author of this book review Michael Johnson - lives on vibrantly through international film festivals, art houses and television reruns although he died in Paris 42 years ago. Just last week in prime time I watched one of his classic films, “Pépé le Moko”, a story of considerable depth that pops up regularly on television. American author Joseph Harriss rightly calls it “Casablanca for grownups”. Other classics abound – “La Grande Illusion”, “Le Quai des Brumes” “Touchez pas au grisbi”, for example. 
Nov 13th 2018
Over the last ten years, research has demonstrated the importance of creative practice in the arts and humanities. They can help maintain health, provide ways of breaking down social barriers and expressing and understanding experiences and emotions, and assist in developing trust, identities, shared understanding and more compassionate communities. So, hopefully, this sidelining of the arts in health terms is changing.
Nov 13th 2018
I am here to sing Will Kemp’s [in the picture below] praises and review this new e-book because I have been studying with Will since January 2016, long distance but close in heart—Will lives in Britain and I live in the States.
Nov 13th 2018

This address is in part about the musician who has studied as a concert pianist, but does not pursue the narrow and precise field for which he has been trained, yet does not quit; but does not often play solo recitals nor concerts, nor chamber music, nor strict lieder activities

Nov 2nd 2018
Writing is such hard work that those of us who dabble in prose often dread looking at the “white bull” – Hemingway’s term for a blank sheet of paper waiting to be filled up with our words. Will we defeat the bull today? It’s always a tossup. The stress and strain of writing perhaps explains why so many writers seek an outlet in the visual arts, particularly painting and sculpture. Visual output satisfies the hunger to create, and, as a bonus, the art form is more free and spontaneous. Great writers have produced great paintings. Look at Victor Hugo, Guillaume Apollinaire, Rudyard Kipling, Dante Gabriel Rossetti. Even more interesting to me is the somewhat lesser phenomenon of pianists who paint. They are seeking the same release, the same soulagement, the same need to liberate themselves. 
Nov 1st 2018
Modern life does have many benefits, but when it persuades us to use transport, sit in a chair at work, or watch TV for extended periods, we increasingly have to turn to medicine for solutions because these habits are killing hundreds of millions of us each year. With 70% of people in the US on prescription drugs (50% in the UK), it seems that as lifespan inches upwards, disease is skyrocketing. The irony is that many advances in modern medicine are firefighting those very problems that modern life itself has created.
Oct 30th 2018
It’s important to note that all studies, including our own, only show an association between the herpes virus and Alzheimer’s – they don’t prove that the virus is an actual cause. Probably the only way to prove that a microbe is a cause of a disease is to show that an occurrence of the disease is greatly reduced either by targeting the microbe with a specific anti-microbial agent or by specific vaccination against the microbe. Excitingly, successful prevention of Alzheimer’s disease by use of specific anti-herpes agents has now been demonstrated in a large-scale population study in Taiwan. Hopefully, information in other countries, if available, will yield similar results.
Oct 18th 2018
Leaving a major political body is nothing new for mainland Britain. In 409AD, more than 350 years after the Roman conquest of 43AD, the island slipped from the control of the Roman Empire. Much like the present Brexit, the process of this secession and its practical impacts on Britain’s population in the early years of the 5th century remain ill-defined. As with the UK and Brussels, Britain had always been a mixed blessing for Rome. In around 415AD, St Jerome called the island “fertile in tyrants” (meaning usurpers) and late Roman writers portrayed a succession of rebellions in Britain, usually instigated by the army – many of whom would have been born in the province.
Oct 16th 2018
One of the oldest Greek myths, the story of Pandora was first recorded more than 2,500 years ago, in the time of Homer. In the original telling, Pandora was not some innocent girl who succumbed to the temptation to open a forbidden jar......Pandora was deliberately devised to punish humankind for accepting the gift of fire from Prometheus. Essentially a seductive AI fembot, she had no parents, childhood memories, or emotions of any kind, nor would she ever age or die. She was programmed to carry out one malevolent mission: to insinuate herself in an earthly setting and then unseal the jar......With AI/machine learning quickly evolving into a “black box” technology, the symbol of Pandora’s sealed jar has taken on new meaning.
Oct 11th 2018
The Scottish National Gallery in Edinburgh is currently exhibiting a substantial selection of Rembrandt’s paintings, drawings, and prints – focusing on those works that reveal the story of “Britain’s Discovery of the Master.” Exploring the significance of Rembrandt to British collectors, artists, and writers provides us with the occasion to revisit some fifteen major oil paintings.....
Oct 10th 2018
On the fiftieth anniversary of Nicolas Garcia Uriburu’s first coloration, Buenos Aires’ National Museum of Fine Arts pays tribute to the landmark early accomplishment of its native son..........Uriburu’s role as an early environmentalist has never been appreciated outside of his native country. It is sad that this neglect was not remedied in his lifetime, but at least it should be done now; a full-scale retrospective of his pioneering work should be presented in the art world’s capitals, to inspire young artists.
Oct 2nd 2018
The 2018 Nobel Prize in Physiology or Medicine has been awarded to two immunologists for their revolutionary approaches to treat cancer. James Allison, based in the MD Anderson Cancer Center in Houston, Texas, and Tasuku Honjo, based at Kyoto University in Japan, led exciting and groundbreaking work on developing new types of immunotherapy that help our immune system fight cancer.
Sep 20th 2018
We all want other people to “get us” and appreciate us for who we really are. In striving to achieve such relationships, we typically assume that there is a “real me”. But how do we actually know who we are? It may seem simple – we are a product of our life experiences, which we can be easily accessed through our memories of the past. Indeed, substantial research has shown that memories shape a person’s identity......................But it turns out that identity is often not a truthful representation of who we are anyway – even if we have an intact memory. Research shows that we don’t actually access and use all available memories when creating personal narratives. It is becoming increasingly clear that, at any given moment, we unawarely tend to choose and pick what to remember.
Sep 20th 2018
The research, published in the Canadian Medical Association Journal, compared how much mothers reported using cleaning products with the rate of obesity in 757 children at the age of three. Faecal samples were taken from the infants at three to four-months-old and the researchers investigated associations between microbial changes and being overweight at age three. The researchers found a link between heavy use of cleaning products, microbial changes and children with a higher body mass index (BMI). However, higher disinfectant usage was also reported among households with infants who received antibiotics around the time of birth; who were exposed to cigarette smoke; or were delivered by caesarean section. The results may therefore reflect several interlinking factors. Obesity was less likely to occur in breastfed children, but breastfeeding was also linked to lower disinfectant usage, which makes it difficult to tease apart these two factors.
Sep 11th 2018
If there’s a story that unites success in Silicon Valley and the new economy that’s given us iPhones and Uber, it’s that geek innovators are rewarded. Engineer the killer app and the cash will roll in. Big brains mean a big pay day. It may be a new economy, but this is a very old mistake. The idea that those at the top of a business are the ones who should be celebrated makes little sense to anyone who actually works in an organisation like Tesla. They might be the ones who make the headlines, but it’s the ordinary employees who do the work and produce the value.